MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
861 Correlation Between Circulating Adhesion Molecules and Resistin Levels in Hypertensive Type-2 Diabetic Patients Inflammation & Allergy - Drug Targets, February 1, 2011
862 The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress Hypertension Research, January 31, 2011
863 Accuracy of Anthropometric Indexes of Obesity to Predict Diabetes Mellitus Type 2 Among Men and Women With Hypertension American Journal of Hypertension, January 28, 2011
864 Hypertension in Diabetic Nephropathy: Epidemiology, Mechanisms, and Management Advances In Chronic Kidney Disease , January 28, 2011
865 Pre-Pregnancy Body Mass Index and Weight Gain During Pregnancy: Relations with Gestational Diabetes and Hypertension, and Birth Outcomes Maternal and Child Health Journal , January 28, 2011
866 Prevalence of Hypertension in a Population of Healthy Individuals Medical Principles and Practice, January 21, 2011
867 Gender differences in the accuracy of time-dependent blood pressure indices for predicting coronary heart disease: A random-effects modeling approach Gender Medicine, January 21, 2011
868 Aldosterone Producing Adrenal Adenomas are Characterized by Activation of Calcium/Calmodulin-dependent Protein Kinase (CaMK) Dependent Pathways Hormone and Metabolic Research, January 21, 2011
869 Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial Journal of Hypertension, January 19, 2011 Clinical Article
870 Uncontrolled home blood pressure in the morning is associated with nephropathy in Japanese type 2 diabetes Heart and Vessels, January 19, 2011
871 Effects of olmesartan on blood pressure and insulin resistance in hypertensive patients with sleep-disordered breathing Heart and Vessels, January 19, 2011 Clinical Article
872 Blood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugal Full Text BMC Health Services Research, January 18, 2011
873 Obesity-related adjunctive systo–diastolic ventricular dysfunction in patients with hypertension: echocardiographic assessment with tissue Doppler velocity and strain imaging Hypertension Research, January 18, 2011 Clinical Article
874
Coexisting prehypertension and prediabetes in healthy adults: a pathway for accelerated cardiovascular events
Hypertension Research, January 18, 2011
Exclusive Author Commentary
875 Bariatric surgery: results in obesity and effects on metabolic parameters Current Opinion in Lipidology, January 14, 2011
876 The Effect of New Antepartum Weight Gain Guidelines and Prepregnancy Body Mass Index on the Development of Pregnancy-Related Hypertension American Journal of Perinatology, January 13, 2011 Clinical Guideline
877 Osteopathic manipulation as a complementary treatment for the prevention of cardiac complications: 12-Months follow-up of intima media and blood pressure on a cohort affected by hypertension Journal of Bodywork & Movement Therapies , January 12, 2011
878 Pulmonary Arterial Hypertension in Patients With Slow-Flow Vascular Malformations JAMA Dermatology, January 10, 2011
879 Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension Hypertension Research, January 6, 2011 Clinical Article
880 Plasma insulin-like growth factor-1 level and risk of incident hypertension in nondiabetic women Journal of Hypertension, January 5, 2011
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryAs reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryAnthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summary1 Randomized trial of Metformin versus Insulin in the Management of Gestational Diabetes American Journal of Obstetrics and Gynecology, April 19, 2013
2 Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis British Medical Journal, April 10, 2013 Free full text Evidence Based Medicine Review Article
3 Atenolol use is associated with long-term mortality in community-dwelling older adults with hypertension Geriatrics and Gerontology International, April 16, 2013
4 Antihypertensive treatment in diabetic patients- Review of current data Maturitas, April 15, 2013 Review Article
5 Telmisartan as a metabolic sartan: The first meta-analysis of randomized controlled trials in metabolic syndrome Journal of the American Society of Hypertension, April 24, 2013
6 Alcohol Intake and Triglycerides/High-Density Lipoprotein Cholesterol Ratio in Men with Hypertension American Journal of Hypertension, April 3, 2013
7 Evaluation of 9 biomarkers for predicting 10-year cardiovascular risk in patients undergoing coronary angiography: Findings from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study International Journal of Cardiology, April 22, 2013
8 Is Subclinical Hypothyroidism a Cardiovascular Risk Factor in the Elderly? Journal of Clinical Endocrinology and Metabolism, April 5, 2013 Review Article
9 Significance of estimating the glomerular filtration rate for the management of hypertension in type 2 diabetes with microalbuminuria Hypertension Research, April 8, 2013
10 Discovery and Characterization of Alamandine Circulation Research, April 15, 2013
11 ADMA and C-reactive protein as mortality predictors in dialysis patients Central European Journal of Medicine, April 23, 2013
12 Antihypertensive Efficacy of Olmesartan Medoxomil and Ramipril in Elderly Patients with Mild to Moderate Hypertension Grouped According to Renal Function Status High Blood Pressure & Cardiovascular Prevention, April 16, 2013
13 Preeclampsia as a Risk Factor for Diabetes: A Population-Based Cohort Study PLoS Medicine, April 19, 2013 Free full text
14 Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies European Journal of Cancer, April 19, 2013 Review Article
15 Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial European Heart Journal, April 22, 2013
16 Lactotripeptides intake and blood pressure management: A meta-analysis of randomised controlled clinical trials Nutrition, Metabolism & Cardiovascular Diseases, April 10, 2013 Evidence Based Medicine
17 Treatment of Obesity-Related Hypertension in Children and Adolescents Current Hypertension Reports, April 2, 2013 Review Article
18 The Role of Plasma Renin Activity, Age, and Race in Selecting Effective Initial Drug Therapy for Hypertension American Journal of Hypertension, April 19, 2013
19 Long-term clinical follow-up of the multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES) European Heart Journal, April 22, 2013
20 Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction Arteriosclerosis, Thrombosis, and Vascular Biology, April 17, 2013
Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close